Overview Financials News + Filings Key Docs Ownership Insiders
|
Entera Bio Ltd. (ENTX)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | | | | |
|
Returns on Capital |
ROIC (including intangibles) | -14229.2% | 1480.2% | 3962.4% | | | |
ROE | -111.9% | -53.9% | -149.0% | | | |
ROA | -100.2% | -46.8% | -115.1% | | | |
|
Cash Conversion Cycle |
Days sales outstanding | 670.1 | 117.0 | 255.0 | | | |
Days payables outstanding | 61.4 | 162.4 | 199.5 | | | |
Cash conversion cycle | 608.6 | -45.5 | 55.5 | | | |
|